Imagine a tea party, where instead of tea, they were serving only Kool-Aid. Not only did you have to drink it, no questions asked, but you had to say it was tea. Despite the bright cherry red color, the unmistakable smell from the artificial flavoring, and maybe even the big Kool-Aid Pitcher symbol with the …
For many of us in the biomedical research field, we have always wanted to be a professor and run our own research lab even if it meant the gauntlet of the dreaded academic job search. For some it is fair to say that that goal is really a passion, a dream. However, to achieve …
The tragic 9.0 earthquake and tsunamis that hit Japan a few weeks ago are having lasting consequences not only for Japan, but also for the world via radiation. One area of particular concern is the radiation that has leaked and is continuing to leak from the damaged nuclear reactors. At this point, the radiation …
A reality check on the radiation spreading across the globe Read More »
The U.S. House of Representatives may vote as early as tomorrow on a Continuing Resolution (CR) that includes a swath of cuts across the federal budget including a 5+% cut for NIH. Such a cut would have devastating consequences for not only research generally and the U.S. economy, but also specifically for stem cell research. …
Action needed: US House to vote tomorrow on CR to slash research funding Read More »
Can one creature directly give another creature cancer? It appears so in dogs and that cancer is highly contagious. When we think about transplants of cells, we think about hospitals and high-tech equipment used to give patients stem cells or other types of cells to help treat them for a disease. Generally cancer patients are …
Contagious cancer: the allograft your dog doesn’t want Read More »
There is a kind of invisible cultural wall between patients such as cancer patients and biomedical scientists like me, but this wall does not have to exist and indeed it is a negative wall as patients, scientists, doctors, agencies, and advocates can achieve far more together than apart. But the wall is surprisingly strong. Last …
The FDA has given Advanced Cell Technology (ACT) the go ahead to begin their clinical trial using retinal progenitor cells derived from hESC by clearing the company’s IND application, bringing hope to those with vision loss and even blindness. The trial will be a combined Phase I/II to treat Stargardt’s Macular Dystrophy and has huge …
One question I am frequently asked by readers and colleagues is “what other stem cell blogs or bloggers can you recommend that are written by a stem cell scientist and updated on a regular basis?” The simple but surprising answer: there are none. It’s lonely out here in cyberspace! (2020 update: The good news today …
How many scientist bloggers does it take to change a light bulb? Read More »
CIRM Board Member, Jeff Sheehy, has a wonderful piece in Nature Medicine on why patient advocates play a critical role in decision making on research priorities (hat tip to Amy Adams who first blogged on Sheehy’s piece). Patient advocates bring a unique and valuable perspective to the table. Their role in guiding CIRM research funding …
Why scientists must be advocates too: Jeff Sheehy Read More »
Dr. James Sherley, the scientist behind the lawsuit against federally-funded ES cell research, has penned an opinion piece in The Daily Caller today calling on NIH to, in his words, ‘do the right thing.’ However, what Sherley is really asking is for the NIH, other stem cell scientists, and all Americans to think like he …
James Sherley of anti-ESC lawsuit calls on NIH to think like he does Read More »